Menu

• Ask a Health Expert about HYPERBILIRUBINAEMIA
• Post Your Side Effect related to HYPERBILIRUBINAEMIA
• HYPERBILIRUBINAEMIA and FDA Warnings
• HYPERBILIRUBINAEMIA in Patients Wiki
• Report HYPERBILIRUBINAEMIA in Drug Side Effect Survey

HYPERBILIRUBINAEMIA side effect

What is HYPERBILIRUBINAEMIA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Nebilet Side Effects Report #5661853-2
Physician from GERMANY reported NEBILET problem on Mar 06, 2008. Male patient, 70 years of age, was treated with NEBILET. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, jaundice, . NEBILET dosage: unknown. During the same period patient was treated with ASPIRIN, SPIRIVA, ACETYLCYSTEINE, FUROSEMIDE, DIGOXIN, MARCUMAR, SIMVASTATIN, THIAMAZOL. Patient recovered.

Cefuroxime Side Effects Report #5589701-X
CEFUROXIME problem was reported by a Physician from INDIA on Jan 04, 2008. Female patient, 27 years of age, was diagnosed with prophylaxis and was treated with CEFUROXIME. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . CEFUROXIME dosage: 750MG THREE TIMES PER DAY. During the same period patient was treated with AUGMENTIN. Patient was hospitalized. Patient recovered.

Supacef Side Effects Report #5591840-4
Physician from INDIA reported SUPACEF problem on Jan 14, 2008. Male patient, 49 years of age, was treated with SUPACEF. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . SUPACEF dosage: unknown. Patient recovered.

Supacef Side Effects Report #5591841-6
SUPACEF problem was reported by a Physician from INDIA on Jan 14, 2008. Male patient, 78 years of age, was treated with SUPACEF. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . SUPACEF dosage: unknown. Patient recovered.


Supacef Side Effects Report #5591842-8
Physician from INDIA reported SUPACEF problem on Jan 14, 2008. Male patient, 76 years of age, was treated with SUPACEF. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . SUPACEF dosage: unknown. Patient recovered.

Supacef Side Effects Report #5591843-X
SUPACEF problem was reported by a Physician from INDIA on Jan 14, 2008. Male patient, 63 years of age, was treated with SUPACEF. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . SUPACEF dosage: unknown. Patient recovered.

Supacef Side Effects Report #5591844-1
Physician from INDIA reported SUPACEF problem on Jan 14, 2008. Male patient, 50 years of age, was treated with SUPACEF. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . SUPACEF dosage: unknown. Patient recovered.

Emtricitabine Side Effects Report #5603048-4
EMTRICITABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2008. Female patient, 34 years of age, weighting 116.8 lb, was diagnosed with hiv infection, pulmonary tuberculosis, medical diet and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . EMTRICITABINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ, ISONIAZID, RIFAMPICIN, PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE, PYRIDOXINE. Patient was hospitalized. Patient recovered.

Emtricitabine Side Effects Report #5570160-8
Consumer or non-health professional from UNITED STATES reported EMTRICITABINE problem on Dec 12, 2007. Female patient, 34 years of age, weighting 116.8 lb, was diagnosed with hiv infection, pulmonary tuberculosis, medical diet and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . EMTRICITABINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ, ISONIAZID, RIFAMPICIN, PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE, PYRIDOXINE. Patient was hospitalized. Patient recovered.


Taxol Side Effects Report #5479275-6
TAXOL problem was reported by a Physician from JAPAN on Oct 01, 2007. Female patient, 70 years of age, was diagnosed with ovarian cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, inappropriate antidiuretic hormone secretion, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, TRICHLORMETHIAZIDE, KYTRIL, DECADRON, RESTAMIN. Patient was hospitalized. Patient recovered.

Duloxetine Side Effects Report #5443258-2
Physician from RUSSIAN FEDERATION reported DULOXETINE HYDROCHLORIDE problem on Aug 22, 2007. Female patient, 22 years of age, was diagnosed with depression and was treated with DULOXETINE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . DULOXETINE HYDROCHLORIDE dosage: 120 MG, DAILY (1/D). During the same period patient was treated with AMITRIPTYLINE, DIPHENHYDRAMINE, METAMIZOL SODIQUE, DICLOFENACO. Patient recovered.

Avastin Side Effects Report #5445564-4
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Aug 23, 2007. Male patient, 50 years of age, weighting 280.0 lb, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . AVASTIN dosage: unknown. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5446072-7
Health Professional from UNITED STATES reported CISPLATIN problem on Aug 24, 2007. Male patient, 62 years of age, was diagnosed with metastatic gastric cancer, prophylaxis and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, hyperglycaemia, jaundice cholestatic, lobar pneumonia, metabolic acidosis, renal failure, . CISPLATIN dosage: unknown. During the same period patient was treated with DEXAMETHASONE, EMEND, LORAZEPAM, ONDANSETRON. Patient was hospitalized. Patient recovered.

Topamax Side Effects Report #5407364-0
TOPAMAX problem was reported by a Physician from SERBIA AND MONTENEGRO on May 30, 2007. Male patient, weighting 4.63 lb, was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, intraventricular haemorrhage neonatal, . TOPAMAX dosage: unknown. During the same period patient was treated with LAMOTRIGINE, VALPROATE. Patient recovered.


Duloxetine Side Effects Report #5418140-7
Physician from RUSSIAN FEDERATION reported DULOXETINE HYDROCHLORIDE problem on Aug 03, 2007. Female patient, 22 years of age, was diagnosed with depression and was treated with DULOXETINE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . DULOXETINE HYDROCHLORIDE dosage: 120 MG, DAILY (1/D). During the same period patient was treated with AMITRIPTYLINE, DIPHENHYDRAMINE, METAMIZOL SODIQUE, DICLOFENACO. Patient recovered.

Bevacizumab Side Effects Report #5425510-X
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Aug 14, 2007. Male patient, 53 years of age, weighting 229.3 lb, was diagnosed with follicular thyroid cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, hyponatraemia, . BEVACIZUMAB dosage: 10 MG/KG, D1,15,29. During the same period patient was treated with SUNITINIB MALATE. Patient recovered.

Sutent Side Effects Report #5377729-4
Physician from FRANCE reported SUTENT problem on June 21, 2007. Female patient, 45 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, jaundice, liver disorder, thrombocytopenia, . SUTENT dosage: DAILY DOSE:50MG. Patient recovered.

Lapatinib Side Effects Report #5384198-7
LAPATINIB problem was reported by a Physician from ITALY on July 04, 2007. Female patient, 44 years of age, weighting 372.6 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, ill-defined disorder, thrombocytopenia, . LAPATINIB dosage: 1250MGM2 PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Neoprofen Side Effects Report #5386297-2
Pharmacist from UNITED STATES reported NEOPROFEN problem on July 10, 2007. Male patient, weighting 2.22 lb, was diagnosed with patent ductus arteriosus and was treated with NEOPROFEN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . NEOPROFEN dosage: unknown. During the same period patient was treated with CEFOTAXIME, CLINDAMYCIN, IV FAT EMULSIONK, FENTANYL, TOBRAMYCIN, VANCOMYCIN, DOPAMINE. Patient recovered.


Sutent Side Effects Report #5377729-4
SUTENT problem was reported by a Physician from FRANCE on June 21, 2007. Female patient, 45 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, jaundice, liver disorder, thrombocytopenia, . SUTENT dosage: DAILY DOSE:50MG. Patient recovered.

Lapatinib Side Effects Report #5384198-7
Physician from ITALY reported LAPATINIB problem on July 04, 2007. Female patient, 44 years of age, weighting 372.6 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, ill-defined disorder, thrombocytopenia, . LAPATINIB dosage: 1250MGM2 PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Neoprofen Side Effects Report #5386297-2
NEOPROFEN problem was reported by a Pharmacist from UNITED STATES on July 10, 2007. Male patient, weighting 2.22 lb, was diagnosed with patent ductus arteriosus and was treated with NEOPROFEN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . NEOPROFEN dosage: unknown. During the same period patient was treated with CEFOTAXIME, CLINDAMYCIN, IV FAT EMULSIONK, FENTANYL, TOBRAMYCIN, VANCOMYCIN, DOPAMINE. Patient recovered.

Ritonavir Side Effects Report #5767776-2
Consumer or non-health professional from UNITED STATES reported RITONAVIR SOFT GELATIN CAPSULES problem on June 04, 2008. Male patient, 37 years of age, was diagnosed with hiv infection and was treated with RITONAVIR SOFT GELATIN CAPSULES. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . RITONAVIR SOFT GELATIN CAPSULES dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, JUICE PLUS, NAPROXEN, IBUROFEN, AMOXICILLIN, PETHIDINE HYDROCHLORIDE. Patient recovered.

Bevacizumab Side Effects Report #5774200-2
BEVACIZUMAB problem was reported by a Physician from JAPAN on June 02, 2008. Male patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . BEVACIZUMAB dosage: 10 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, LOXONIN, URSO, MUCOSTA, FAMOTIDINE. Patient recovered.

Ritonavir Side Effects Report #5775022-9
Health Professional from UNITED STATES reported RITONAVIR SOFT GELATIN CAPSULES problem on June 10, 2008. Male patient, 37 years of age, weighting 172.2 lb, was diagnosed with hiv infection and was treated with RITONAVIR SOFT GELATIN CAPSULES. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . RITONAVIR SOFT GELATIN CAPSULES dosage: unknown. During the same period patient was treated with TRUVADA, ATAZANAVIR, JUICE PLUS, NAPROXEN, ADVIL, AMOXILIN. Patient recovered.

Isentress Side Effects Report #5725740-3
ISENTRESS problem was reported by a Pharmacist from UNITED STATES on Apr 28, 2008. Male patient, 44 years of age, was diagnosed with hiv infection and was treated with ISENTRESS. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . ISENTRESS dosage: unknown. During the same period patient was treated with PREZISTA. Patient recovered.

Amlor Side Effects Report #5728079-5
Health Professional from FRANCE reported AMLOR problem on Apr 25, 2008. Male patient, weighting 176.4 lb, was treated with AMLOR. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, transaminases increased, . AMLOR dosage: unknown. During the same period patient was treated with ISONIAZID, RIFADIN, PYRAZINAMIDE, MYAMBUTOL, EFFEXOR, INSULIN, ENOXAPARIN, RIFATER. Patient recovered.

Zosyn Side Effects Report #5739239-1
ZOSYN problem was reported by a Physician from UNITED STATES on May 12, 2008. Male patient, weighting 153.1 lb, was diagnosed with peritonitis, escherichia infection, bacteroides infection, clostridial infection, metastatic renal cell carcinoma and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . ZOSYN dosage: unknown. During the same period patient was treated with SUNITINIB, COLACE, PROTONIX, OXYCONTIN. Patient recovered.

Zosyn Side Effects Report #5740537-6
Physician from UNITED STATES reported ZOSYN problem on May 12, 2008. Male patient, weighting 153.1 lb, was diagnosed with peritonitis, escherichia infection, bacteroides infection, clostridial infection, metastatic renal cell carcinoma and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . ZOSYN dosage: unknown. During the same period patient was treated with SUTENT, COLACE, PROTONIX, OXYCONTIN. Patient recovered.

Propofol Side Effects Report #5754162-4
PROPOFOL problem was reported by a Physician from ISRAEL on May 28, 2008. Male patient, 52 years of age, was diagnosed with sedation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, hypertriglyceridaemia, metabolic acidosis, propofol infusion syndrome, renal failure acute, rhabdomyolysis, . PROPOFOL dosage: unknown. During the same period patient was treated with ATRACRIUM. Patient recovered.

Argatroban Side Effects Report #5693817-7
Physician from JAPAN reported ARGATROBAN problem on Mar 27, 2008. Female patient, 81 years of age, was diagnosed with cerebral infarction and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, jaundice, . ARGATROBAN dosage: unknown. During the same period patient was treated with EDARAVONE, PLAVIX. Patient was hospitalized. Patient recovered.

Argatroban Side Effects Report #5707247-2
ARGATROBAN problem was reported by a Physician from JAPAN on Apr 07, 2008. Female patient, 81 years of age, was diagnosed with cerebral infarction and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, jaundice, . ARGATROBAN dosage: unknown. During the same period patient was treated with EDARAVONE, PLAVIX. Patient was hospitalized. Patient recovered.

Lapatinib Side Effects Report #5719608-6
Physician from ITALY reported LAPATINIB problem on Apr 18, 2008. Female patient, 49 years of age, weighting 172.0 lb, was diagnosed with breast cancer metastatic and was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient died on 04/14/2008.

Ritonavir Side Effects Report #5720470-6
RITONAVIR SOFT GELATIN CAPSULES problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2008. Male patient, 37 years of age, was diagnosed with hiv infection and was treated with RITONAVIR SOFT GELATIN CAPSULES. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . RITONAVIR SOFT GELATIN CAPSULES dosage: 100MG DAILY. During the same period patient was treated with ATAZANAVIR SULPHATE, TRUVADA, JUICE PLUS, NAPROXEN, IBUPROFEN, AMOXICILLIN. Patient recovered.

Ritonavir Side Effects Report #5720534-7
Health Professional from UNITED STATES reported RITONAVIR SOFT GELATIN CAPSULES problem on Apr 18, 2008. Male patient, 37 years of age, weighting 172.2 lb, was diagnosed with hiv infection and was treated with RITONAVIR SOFT GELATIN CAPSULES. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . RITONAVIR SOFT GELATIN CAPSULES dosage: unknown. During the same period patient was treated with TRUVADA, ATAZANAVIR SULPHATE, JUICE PLUS, NAPROXEN, ADVIL, AMOXILIN. Patient recovered.

Truvada Side Effects Report #5721039-X
TRUVADA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 21, 2008. Male patient, 37 years of age, weighting 172.2 lb, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . TRUVADA dosage: unknown. During the same period patient was treated with REYATAZ, NORVIR, ALEVE, JUICE PLUS, ADVIL. Patient recovered.

Emtricitabine Side Effects Report #5346140-4
Consumer or non-health professional from UNITED STATES reported EMTRICITABINE problem on May 31, 2007. Male patient, 33 years of age, weighting 143.3 lb, was diagnosed with hiv infection and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . EMTRICITABINE dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, DIDANOSINE, CETIRIZINE. Patient recovered.

Lapatinib Side Effects Report #5357376-0
LAPATINIB problem was reported by a Physician from ITALY on June 06, 2007. Female patient, 44 years of age, weighting 372.6 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, ill-defined disorder, thrombocytopenia, . LAPATINIB dosage: 1250MGM2 PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Copegus Side Effects Report #5360679-7
Pharmacist from FRANCE reported COPEGUS problem on June 07, 2007. Female patient, 56 years of age, weighting 132.3 lb, was diagnosed with hepatitis c, depression and was treated with COPEGUS. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . COPEGUS dosage: unknown. During the same period patient was treated with PEGASYS, FONZYLANE, OGAST, SEROPRAM, DAFLON. Patient recovered.

Bevacizumab Side Effects Report #5315911-2
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Apr 24, 2007. Female patient, 61 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . BEVACIZUMAB dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, FENTANYL, MORPHINE SULPHATE, NEURONTIN, COMPAZINE, DULCOLAX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5319470-X
Physician from UNITED STATES reported BEVACIZUMAB problem on May 04, 2007. Female patient, weighting 111.0 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . BEVACIZUMAB dosage: 879 MG, Q3W. During the same period patient was treated with XELODA, ABRAXANE. Patient was hospitalized and became disabled. Patient recovered.

Copegus Side Effects Report #5327271-1
COPEGUS problem was reported by a Pharmacist from FRANCE on May 10, 2007. Female patient, 56 years of age, was diagnosed with hepatitis c and was treated with COPEGUS. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . COPEGUS dosage: unknown. During the same period patient was treated with PEGASYS. Patient recovered.

Lexiva Side Effects Report #5290648-7
Physician from JAPAN reported LEXIVA problem on Apr 02, 2007. Male patient, 39 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with LEXIVA. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, pyrexia, . LEXIVA dosage: 700MG TWICE PER DAY. During the same period patient was treated with NORVIR, REYATAZ, VIREAD, EPZICOM, RETROVIR, EPIVIR, ZERIT, VIRACEPT. Patient recovered.

Bevacizumab Side Effects Report #5297507-4
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Female patient, 61 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . BEVACIZUMAB dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, FENTANYL, MORPHINE SULPHATE, NEURONTIN, COMPAZINE, DULCOLAX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5303759-4
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Apr 18, 2007. Female patient, weighting 111.0 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . BEVACIZUMAB dosage: 879 MG, Q3W. During the same period patient was treated with XELODA, ABRAXANE. Patient was hospitalized and became disabled. Patient recovered.

Cisplatin Side Effects Report #5304731-0
CISPLATIN problem was reported by a Health Professional from UNITED STATES on Apr 20, 2007. Male patient, 62 years of age, was diagnosed with metastatic gastric cancer, prophylaxis, vomiting, nausea and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, hyperglycaemia, metabolic acidosis, renal failure, . CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, DEXAMETHASONE, EMEND, LORAZEPAM, ONDANSETRON, COMPAZINE, ZOFRAN. Patient was hospitalized. Patient recovered.

Zosyn Side Effects Report #5308133-2
Physician from UNITED STATES reported ZOSYN problem on Apr 18, 2007. Male patient, weighting 153.1 lb, was diagnosed with peritonitis, escherichia infection, bacteroides infection, clostridial infection, metastatic renal cell carcinoma and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, post procedural complication, . ZOSYN dosage: unknown. During the same period patient was treated with SUNITINIB, TEMSIROLIMUS, COLACE, PROTONIX, OXYCONTIN. Patient recovered.

Precedex Side Effects Report #5316482-7
PRECEDEX problem was reported by a Pharmacist from JAPAN on Apr 19, 2007. Male patient, 57 years of age, weighting 114.6 lb, was treated with PRECEDEX. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . PRECEDEX dosage: unknown. During the same period patient was treated with CEFTAZIDIME, DIPRIVAN, FENTANYL, VECURONIUM BROMIDE, NICARDIPINE HYDROCHLORIDE, ETILEFRINE HYDROCHLORIDE, SEVOFLURANE, MIDAZOLAM. Patient was hospitalized. Patient recovered.

Elitek Side Effects Report #5253398-9
Physician from UNITED STATES reported ELITEK problem on Feb 26, 2007. Male patient, weighting 218.5 lb, was diagnosed with tumour lysis syndrome and was treated with ELITEK. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, septic shock, . ELITEK dosage: unknown. During the same period patient was treated with IDARUBICIN, CYTARABINE, NEXIUM, SYNTHROID, ZANAFLEX, ELAVIL, NEURONTIN. Patient died on 02/20/2007.

Cymevene Side Effects Report #5255290-2
CYMEVENE problem was reported by a Consumer or non-health professional from SWEDEN on Feb 22, 2007. Male patient, 28 years of age, was treated with CYMEVENE. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . CYMEVENE dosage: REPORTED FORM: POWDER FOR SOLUTION FOR INFUSION. REGIMEN WAS REPORTED AS 2 TIMES 175 MG.. During the same period patient was treated with CELLCEPT, MERONEM, AMBISOME, DIFLUCAN, PRECORTALON, BACTRIM, SANDIMMUNE. Patient was hospitalized. Patient died on 12/28/2001.

Cymevene Side Effects Report #5255384-1
Health Professional from SWEDEN reported CYMEVENE problem on Feb 22, 2007. Male patient, 37 years of age, was treated with CYMEVENE. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, thrombocytopenia, . CYMEVENE dosage: unknown. During the same period patient was treated with MERONEM, PRECORTALON, BACTRIM, SANDIMMUNE, AMBISOME. Patient was hospitalized. Patient died on 12/05/2004.